INERHC EXPERT REFERENCES
Below you will find only the references which are not subject to confidentiality:
Cost-effectiveness analysis of Natalizumab for multiple sclerosis treatment in Slovenia
April 2010
Mrkaić M., Živkovič A., " Cost-Effectiveness Analysis of Natalizumab for Multiple Sclerosis Treatment in Slovenia", April 2010
Budget impact analysis of introduction of Natalizumab for multiple sclerosis treatment in Slovenia
April 2010
Mrkaić M., Živkovič A., " Budget impact analysis of introduction of Natalizumab for multiple sclerosis treatment in Slovenia ", April 2010
Additional health insurance from tax perspective: Effects of additional health insurance on public finance and national economy in Slovenia
October 2009
Analysis of economic effects of palivizumab usage in Slovenian setting: Cost-effectiveness of palivizumab in the cases of heavier respiratory infections with respiratory syncytial virus for high-risk children
June 2009
Mrkaić M., Živkovič A., "Analysis of economic effects of palivizumab consumption in Slovenian setting: Cost-effectiveness of palivizumab in the cases of heavier respiratory infections with respiratory syncytial virus for high-risk children", June 2009
Effects of potential transfer of additional health insurance into compulsory health insurance from the national economy and public finance perspectives
September 2008
Mrkaić M., Pezdir R., Živkovič A., "Effects of potential transfer of additional health insurance into compulsory health insurance from the national economy and public finance perspectives", September 2008
Economic analysis of the Slovenian pharmacy financing system
July 2008
Mrkaić M., Živkovič A., Pezdir R., "Economic analysis of the pharmacy financing system", July 2008
INERHC annual economic research of the Slovenian health care system
June 2008
Živkovič A., Mrkaić M., Pezdir R., Hočevar F., Eržen I., Albreht T.: Zdravstvena ekonomika – revija za ekonomske raziskave v zdravstvu, June 2008
Health Technology Assessment (HTA) guidelines, 1st Edition
January 2008
Živkovič A., Pezdir R., Mrkaić M.: Health Technology Assessment (HTA) guidelines, 1st Edition, January 2008
Differential cost-effectiveness of natalizumab compared to interferon beta-1a: Analysis for Slovenia
January 2008
Mrkaić M., Pezdir R., "Differential cost-effectiveness of natalizumab compared to interferon beta-1a: Analysis for Slovenia", January 2008
Economic analysis of cost-effectiveness of natalizumab in multiple sclerosis treatment
December 2007
Mrkaić M., Pezdir R., "Economic analysis of cost-effectiveness of natalizumab in multiple sclerosis treatment", December 2007
The article is available here.
Drug spend cost containment measures of pricing and reimbursement policies from the perspective of economic efficiency
November 2007
Živkovič A., " Drug spend cost containment measures of pricing and reimbursement policies from the perspective of economic efficiency", Bilten: ekonomika, organizacija, informatika v zdravstvu, december 2007, letnik 23, številka 4 (IVZ)
http://www.ivz.si/javne_datoteke/bilten/datoteke/85-Zivkovic.pdf
Restrictions of hospital operation: roots of inefficiency of Slovenian health care
November 2007
Pezdir R, Mrkaić M., "Restrictions of hospital operation: roots of inefficiency of Slovenian health care", Bilten: ekonomika, organizacija, informatika v zdravstvu, december 2007, letnik 23, številka 4 (IVZ)
http://www.ivz.si/javne_datoteke/bilten/datoteke/83-Mrkaic.pdf
Analysis of economic efficiency of public spend allocation in health care
November 2007
Addressee:
- Ministry of Health of the Republic of Slovenia
Expert and financially independent research, which has been prepared based on initiation from the Ministry of Health of the Republic of Slovenia. The research is coping with quantification of inefficiency of the health care spend allocation.
Quantification of economic factors of TYSABRI (natalizumab)
November 2007
Quantification of economic factors of BYETTA (exenatide)
November 2007
Quantification of economic factors of JANUVIA (sitaglipin)
November 2007
Quantification of economic factors of ARCOXIA (etoricoxib)
November 2007
Optimization of salary system in healthcare
November 2007
Addressees:
- Ministry of Health of the Republic of Slovenia
- The Health Insurance Institute of Slovenia (ZZZS)
The document has been prepared based on initiation and wish of The Health Insurance Institute of Slovenia (ZZZS) and consists of a short description of the salary system issues in Slovenian healthcare. The document also proposes some of potential solutions for optimization of the issue.
Optimization of cost-efficiency of drug spend
November 2007
Addressee:
- The Health Insurance Institute of Slovenia (ZZZS)
The document has been prepared based on initiation from The Health Insurance Institute of Slovenia (ZZZS) and consists of description of current health-economic problematic issues (with potential solutions) in the areas of (1) analytics of drug spend and prescription patterns with the purpose of searching for post-marketing clinical studies, (2) analytics of drug spend and prescription patterns with the purpose of rational prescription stimulation model for contractual parties of The Health Insurance Institute of Slovenia (ZZZS).
Regulatory changes in some areas of allocation and regulation of public drug spend
October 2007
Addressee:
- Ministry of Health of the Republic of Slovenia
The document has been prepared based on initiation and wish of the Ministry of Health of the Republic of Slovenia and consists of economic basis and recommendations for potential changes of the following systems: (1) Drug reimbursement system and other systems of public drug spend allocation, (2) Drug pricing regulation, (3) The issues of the current system of post-marketing clinical studies from the perspective of economic efficiency of public drug spend allocation and from the perspective of the effect of post-marketing clinical studies on labor cost and productivity of healthcare professionals.
Evaluation of cost-effectiveness of PROTELOS (strontium ranelate)
August 2007
INERHC economic research: "Is the Slovenian health care system facing a breakdown?"
May 2007
Independent expert research which is, from the perspective of optimization of economic efficiency, trying to cope with areas such as efficient drug spend allocation and drug pricing regulation, issues of management and organization in healthcare, productivity and other problematic areas of health care.
Živkovič A., Pezdir R, Mrkaić M., Hočevar F. "Is the Slovenian health care system facing a breakdown?". Zdravstvena ekonomika – revija za ekonomske raziskave v zdravstvu, May 2007